Skip to Main content Skip to Navigation
Journal articles

Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias

Sandrine Bouchet 1 Brigitte Bauvois 1, *
* Corresponding author
Abstract : Matrix metalloproteinase (MMP)-9 and neutrophil gelatinase-associated lipocalin (NGAL) have gained attention as cancer biomarkers. The inactive zymogen form of MMP-9 (pro-MMP-9) also exists as a disulphide-linked heterodimer bound to NGAL in humans. Leukaemias represent a heterogeneous group of neoplasms, which vary in their clinical behavior and pathophysiology. In this review, we summarize the current literature on the expression profiles of pro-MMP-9 and NGAL as prognostic factors in leukaemias. We also report the expression of the pro-MMP-9/NGAL complex in these diseases. We discuss the roles of (pro)-MMP-9 (active and latent forms) and NGAL in tumour development, and evaluate the mechanisms by which pro-MMP-9/NGAL may influence the actions of (pro)-MMP-9 and NGAL in cancer. Emerging knowledge about the coexpression and the biology of (pro)-MMP-9, NGAL and their complex in cancer including leukaemia may improve treatment outcomes.
Document type :
Journal articles
Complete list of metadatas

Cited literature [104 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02479523
Contributor : Brigitte Bauvois <>
Submitted on : Friday, February 14, 2020 - 3:24:12 PM
Last modification on : Friday, September 18, 2020 - 2:35:04 PM
Long-term archiving on: : Friday, May 15, 2020 - 4:29:57 PM

File

cancers-06-00796.pdf
Publication funded by an institution

Identifiers

Citation

Sandrine Bouchet, Brigitte Bauvois. Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias. Cancers, MDPI, 2014, 6 (2), pp.796-812. ⟨10.3390/cancers6020796⟩. ⟨inserm-02479523⟩

Share

Metrics

Record views

309

Files downloads

654